Sub-Saharan Africa vs United Kingdom: Access to anti-retroviral drugs, male
Sub-Saharan Africa
79.8%
in 2024
United Kingdom
93.0%
in 2023
Sub-Saharan Africa rank
7th
United Kingdom rank
7th
Access to anti-retroviral drugs, male over time
- Sub-Saharan Africa
- United Kingdom
How they compare
United Kingdom currently reports 93.0% against 79.8% in Sub-Saharan Africa, a difference of 13.2%.
That makes United Kingdom's figure about 1.2 times Sub-Saharan Africa's.
Across all 8 years both countries report, United Kingdom has been ahead every year.
Sub-Saharan Africa ranks 7th and United Kingdom ranks 7th of 19 groups.
United Kingdom has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sub-Saharan Africa | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.9% | 92.0% | 36.1% | United Kingdom |
| 2020s | 71.6% | 93.2% | 21.6% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Sub-Saharan Africa or United Kingdom?
- United Kingdom, at 93.0% against 79.8% in Sub-Saharan Africa as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Sub-Saharan Africa and United Kingdom?
- 13.2%, with United Kingdom ahead.
- How many years of comparable data are there for Sub-Saharan Africa and United Kingdom?
- 8 years are reported by both, from 2016 to 2023.
- How do Sub-Saharan Africa and United Kingdom rank globally for access to anti-retroviral drugs, male?
- Sub-Saharan Africa ranks 7th and United Kingdom ranks 7th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.